Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeffrey Billings is active.

Publication


Featured researches published by Jeffrey Billings.


International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1988

Preparation and biodistribution of [125I]IBZM: A potential CNS D-2 dopamine receptor imaging agent

Hank Farn-Iuan Kung; Yu Zhi Guo; Jeffrey Billings; X. Xu; Robert H. Mach; Monte Blau; R.E. Ackerhalt

A new CNS D-2 dopamine receptor imaging agent [125I]IBZM, (S)-3-[125I]-iodo-N-[(1-ethyl-2-pyrrolidinyl)] methyl-2-hydroxy-6-methoxybenzamide, was prepared by either an exchange reaction or by the chloramine-T method. After an i.v. injection, the agent easily passed through the blood-brain barrier and localized in the rat brain. At 2, 15, 30 and 60 min after the injection, the brain uptake was 2.9, 2.3, 1.8 and 0.7% dose/organ, respectively. Regional uptake ratio of striatum/cerebellum (target to nontarget ratio) increased from 1.4 at 30 s to 10.3 at 2 h after the i.v. injection. Digital autoradiography of rat brain sections showed high regional uptake in the caudate putamen and accumbens nucleus, areas known to have a high concentration of the D-2 dopamine receptor. The specific uptake at the D-2 dopamine receptor site was blocked by pretreatment with spiperone, a selective D-2 antagonist. When labeled with 123I (t1/2 = 13 h, 159 keV), [123I]IBZM may be useful for imaging the CNS D-2 dopamine receptor.


International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1988

Comparison of In vivo D-2 dopamine receptor binding of IBZM and NMSP in rat brain

Hank Farn-Iuan Kung; Jeffrey Billings; Yu Zhi Guo; Robert H. Mach

In vivo biodistribution of S- and R-isomers of [125I]IBZM in rats showed a significant initial brain uptake (3.20 and 2.67% dose/organ at 2 min, respectively). The wash-out from the brain was slower for the S-isomer. The striatum to cerebellum ratio for [125I]S-IBZM decreased with an increasing dose of cold carrier or spiperone, suggesting that the brain uptake is stereospecific and saturable, and may be related to the binding of D-2 dopamine receptors. In a dual isotope digital autoradiography study [125I]IBZM and [3H]NMSP(N-methylspiperone) show comparable regional cerebral distribution in rats.


Journal of The Chemical Society, Chemical Communications | 1991

Synthesis, characterization and solid state structure of a neutral gallium(III) amino thiolate complex: a potential radiopharmaceutical for PET imaging

Lynn C. Francesconi; Bo-Li Liu; Jeffrey Billings; Patrick J. Carroll; Grazyna Graczyk; Hank F. Kung

The neutral gallium complex of a bisaminoethanethiol ligand has a square pyramidal coordination geometry with Ga–N and Ga–S bonds.


International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1987

Comparison of [28Br]4-bromoantipyrine and [125I]4-iodoantipyrine: The kinetics of exchange reaction and biodistribution in rats

Bo-Li Liu; Hank Farn-Iuan Kung; Jeffrey Billings; Monte Blau

Kinetics and mechanism of isotope exchange reaction between [82Br]bromide anion and 4-bromoantipyrine (BrAP), and the iodine-bromine exchange reaction between [125I]iodide anion and BrAP were studied. The preparation of [82Br]BrAP followed by exponential exchange law, the kinetics of the exchange reaction is a second-order reaction with an activation energy of 23.3 kcal/mol. The optimal exchange condition for halogen exchange between [125I]iodide and BrAP was by a hydrothermal melt method at 110 degrees C and 5 min reaction time. The partition coefficient at pH 7.0 for IAP and BrAP was 20.9 and 13.5, respectively. However, BrAP, which displayed the lower partition coefficient, showed higher brain uptake in rats than that for IAP (2.0% dose/organ vs 1.74% dose/organ), at 2 min after an i.v. injection.


The Journal of Nuclear Medicine | 1989

In vitro and In vivo Evaluation of [123I]IBZM: A Potential CNS D-2 Dopamine Receptor Imaging Agent

Hank F. Kung; Sangren Pan; Mei-Ping Kung; Jeffrey Billings; Ravindra Kasliwal; John Reilley; Abass Alavi


The Journal of Nuclear Medicine | 1990

In Vivo SPECT Imaging of CNS D-2 Dopamine Receptors: Initial Studies with Iodine-123-IBZM in Humans

Hank F. Kung; Abass Alavi; Wei Chang; Mei-Ping Kung; John W. Keyes; Michael G. Velchik; Jeffrey Billings; Sangren Pan; Richard Noto; Adriana Rausch; John Reilley


The Journal of Nuclear Medicine | 1984

Synthesis and Biodistribution of Neutral Lipid-Soluble Tc-99m Complexes that Cross the Blood-Brain Barrier

Hank F. Kung; M. Molnar; Jeffrey Billings; Robert Wicks; Monte Blau


Journal of Medicinal Chemistry | 1989

New brain perfusion imaging agents based on 99mTc-bis(aminoethanethiol) complexes: stereoisomers and biodistribution.

Hank F. Kung; Yu Zhi Guo; Chi Chou Yu; Jeffrey Billings; Vinayakam Subramanyam; Joseph C. Calabrese


The Journal of Nuclear Medicine | 1990

The characterization of IBF as a new selective dopamine D-2 receptor imaging agent

Mei-Ping Kung; Hank F. Kung; Jeffrey Billings; Yunyun Yang; Raymond Murphy; Abass Alavi


Journal of Medicinal Chemistry | 1985

Synthesis of new bis(aminoethanethiol) (BAT) derivatives: possible ligands for 99mTc brain imaging agents

Hank F. Kung; Yu Cc; Jeffrey Billings; Molnar M; Monte Blau

Collaboration


Dive into the Jeffrey Billings's collaboration.

Top Co-Authors

Avatar

Hank F. Kung

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Mei-Ping Kung

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Abass Alavi

Hospital of the University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bo-Li Liu

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sangren Pan

University of Pennsylvania

View shared research outputs
Researchain Logo
Decentralizing Knowledge